Japanese car parts manufacturer Yazaki will have to pay a $46 million penalty for price-fixing, now that the High Court has refused to hear its appeal of the record competition fine.
The Commonwealth of Australia has resolved its claims against pharmaceutical giant Wyeth over the price it paid to list Effexor on the PBS, months after a high stakes trial wrapped up.
Creditors of the failed Arrium Group have won access to documents handed over by third parties to the company’s administrators for possible civil proceedings against the steel producer, which collapsed owing $2.3 billion.
An appeals court has ordered the judge overseeing a fraudulent concealment trial over Cargill’s $420 million purchase of the Joe White malt business to reconsider his decision to allow an in-house lawyer at Glencore to access “highly confidential” deal documents.
A judge has granted a unit of Queensland Investment Corporation’s request for a confidentiality regime for certain documents discovered in an ongoing legal spat with EnergyAustralia over the $1.78 billion sale of a gas facility in Victoria, but said three EnergyAustralia can view the documents.
Three class actions filed against the Commonwealth of Australia over allegedly toxic foam from government military bases will be heard together.
Viterra has been hit with costs for persisting with a special leave application to the High Court seeking to compel Cargill to turn over emails exchanged with its lawyers at Allens during the sale of its Joe White Maltings business, even after Cargill agreed to waive privilege and produced the documents.
The Australia and New Zealand Banking Group told the court on Tuesday that it urgently needs a statement of facts, during the first hearing in the highly anticipated criminal cartel case against three investment banks.
The stakes will be high for both sides when some of the country’s top competition lawyers face off against the ACCC Tuesday in the first hearing in a closely watched criminal cartel case against three investment banks overĀ a $2.5 billion ANZ institutional share placement.
The Australian Patent Office has thrown out Fisher & Paykel Healthcare’s opposition to a patent for a gas supply apparatus used to treat respiratory conditions owned by California-based medical equipment manufacturer, ResMed.